Navigating Growing Pains for Life Science Companies Experiencing Rapid Growth
10:30 AM – 11:30 AM |
Fast-growing pharmaceutical companies face a delicate balance between planning for expansion, uncertain capital availability and compliance risks. The purpose of this discussion is to review these challenges from the perspective of real estate needs, timing, implementing security, inventory protocols, new SOPs, and cGXP standards — all while addressing increasing performance/production demands. Pat Gallagher will moderate the discussion with a panel of executives in the pharmaceutical industry who have navigated these challenges. The panel will draw on their experiences and lessons learned. Main takeaways will include:
– Navigating compliance issues: the risks and planning for them
– Often overlooked Operational facets of growing pains and the impact they can have to daily operations
– Negotiating uncertainties in real estate needs and capital
Pat Gallagher | President & CEO | Hereva Consultants
Founder and CEO of Hereva Consultants, Patrick is a seasoned professional with over 25 years of experience in the construction industry. Primarily working in the research and technology sectors, he has spent the past 18 years specializing in client representation and project management services, focusing on the Biotechnology sector. Patrick understands the requirements of facilities services, the importance of maintaining operations, fast response and internal customer service balanced with company policy – all while keeping the client’s financial goals and corporate values at the forefront.
Education: Bachelors of Science (Hons) — Cost Management of Building Engineering Services, UK; BTec Higher National Diploma – Building Engineering Services (Commercial), UK; BTec National Diploma – Building Engineering Services (Commercial), UK
Charles Pappalardo | VP, Global Operations & Real Estate | Vertex Pharmaceuticals
Chuck maintains over 25 years of experience within the science and technology sector being immediately involved in global real estate, large scale capital projects, facilities engineering and management, global environment, health and safety, corporate security and related technical and operational support functions. He possesses extensive knowledge in developing science and technology facilities from the ground up having been involved in all stages of the process: developing and managing successful project teams in the planning, construction, delivery and validation of multiple large scale facilities worldwide. Chuck’s current responsibilities at Vertex include oversight over the company’s facility global assets including Planning, Construction, Operations, Security, EHS, Business Continuity and Real Estate. Chuck is a member in the International Society of Pharmaceutical Engineers (ISPE), International Facilities Managers Association (IFMA) and CORNET.
Chuck is a graduate of both Norwich University and Umass Lowell obtaining both undergraduate and graduate degrees in Engineering Technology and Environmental Science. Chairman, Seaport Transportation Management Association
Ed Dondero | Director of Real Estate & Planning | Biogen
Ed has had over thirty years of experience in the biomedical field while also working for Tufts University and Shire Pharmaceuticals. His responsibilities have included the management of small and large lab, office and manufacturing projects, energy management and the supervision of an operation and maintenance staff. Presently his duties are the oversight and administration of global real estate and master space planning functions.
Education: BS in Construction Management from Wentworth Institute of Technology and an MBA from Bentley College
Jeffrey Mackay | MBA, FMP, Vice President, Facilities, Real Estate and Supply Chain | Foundation Medicine
Jeff is the Vice President of Facilities, Real Estate and Supply Chain at Foundation Medicine. In this capacity, Jeff is responsible for real estate, facilities management, lab asset management, security, and EH&S at all of FMI’s facilities in MA, CA, NC and Germany. Additionally, Jeff is responsible for FMI’s global supply chain. Prior to Foundation Medicine, Jeff served as the Senior Director of Global Operations at Vertex Pharmaceuticals. Previous roles also includes consulting for Real Estate and FM functions across the Pharmaceutical, Healthcare and Higher Education sectors. His clients included Johnson and Johnson, Genentech, Kaiser Permanente and Unilever. Jeff has also held leadership roles in FM and Real Estate for Pfizer, Medtronic and AIG.
Jeff holds a B.A from Brandeis University and an MBA from Suffolk University. He has earned the Facilities Management Professional designation from IFMA as well as a Six Sigma Greenbelt